General Information of DTT (ID: TTNJA0C)

DTT Name Enhancer of zeste homolog 1 (EZH1) DTT Info
Gene Name EZH1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
DS-3201b DMI69E5 T-cell leukaemia 2A90 Phase 2 [1]
DS-3201 DMRLPFG Acute lymphoblastic leukaemia 2A85 Phase 1 [2]
HH2853 DMQIE58 Non-hodgkin lymphoma 2B33.5 Phase 1 [3]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK343 DM9QU5Y Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Development of new agents for peripheral T-cell lymphoma. Expert Opin Biol Ther. 2019 Mar;19(3):197-209.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of HaiHe Biopharma.
4 Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2. ACS Med Chem Lett. 2012 Oct 19;3(12):1091-6.